glp-1 influencers How big a deal will drugs (and associated) be? Serena Williams in a Super Bowl ad for a GLP-1 programme. Let that sink in. Not a fringe influencer. Not a before-and-after Exclusive | This star's GLP-1

This dual-action approach addresses multiple facets of the underlying pathophysiology of obesity and insulin resistance, making it a promising therapeutic option for individuals struggling with weight loss and metabolic dysregulation

Compounded products are typically paid for out-of-pocket, which can be more financially prohibitive than branded therapies covered by insurance

This aggressive titration schedule may contribute to the higher side effect rates seen in early treatment weeks

Most patients have not been told them

A collapse in margin structure: if Hims shifts from a high-margin compounded drug provider to a lower-margin drug distribution channel, profitability could drop sharply

doi: 10.1111/j.1742-1241.2009.02265.x [DOI] [PubMed] [Google Scholar] 210